X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (148) 148
Publication (7) 7
Book / eBook (3) 3
Book Chapter (1) 1
Book Review (1) 1
Dissertation (1) 1
Trade Publication Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (70) 70
cardiac & cardiovascular systems (56) 56
male (54) 54
female (52) 52
index medicus (51) 51
aged (49) 49
middle aged (47) 47
percutaneous coronary intervention (34) 34
clopidogrel (32) 32
treatment outcome (31) 31
cardiac patients (25) 25
cardiovascular (23) 23
care and treatment (23) 23
heart attacks (22) 22
risk factors (21) 21
myocardial infarction (20) 20
platelet aggregation inhibitors - adverse effects (20) 20
prasugrel (20) 20
transluminal angioplasty (20) 20
acute coronary syndromes (19) 19
ticlopidine - analogs & derivatives (19) 19
abridged index medicus (18) 18
heart attack (18) 18
hemorrhage - chemically induced (18) 18
platelet aggregation inhibitors - administration & dosage (18) 18
angioplasty (17) 17
platelet aggregation inhibitors - therapeutic use (17) 17
prospective studies (17) 17
time factors (17) 17
acute coronary syndrome (16) 16
cardiology and cardiovascular medicine (16) 16
coronary heart disease (16) 16
intervention (16) 16
internal medicine (15) 15
myocardial infarction - therapy (15) 15
peripheral vascular disease (15) 15
adult (14) 14
mortality (14) 14
double-blind method (13) 13
outcomes (13) 13
therapy (13) 13
ticlopidine - administration & dosage (13) 13
abciximab (12) 12
acute coronary syndrome - therapy (12) 12
management (12) 12
antibodies, monoclonal - adverse effects (11) 11
association task-force (11) 11
drug therapy (11) 11
immunoglobulin fab fragments - adverse effects (11) 11
acute myocardial-infarction (10) 10
analysis (10) 10
hematology (10) 10
patient outcomes (10) 10
patients (10) 10
prasugrel hydrochloride (10) 10
purinergic p2y receptor antagonists - administration & dosage (10) 10
usage (10) 10
antibodies, monoclonal - therapeutic use (9) 9
blood platelets - drug effects (9) 9
cardiology (9) 9
follow-up studies (9) 9
immunoglobulin fab fragments - therapeutic use (9) 9
percutaneous coronary intervention - adverse effects (9) 9
pharmacology & pharmacy (9) 9
platelet function tests (9) 9
prasugrel hydrochloride - adverse effects (9) 9
prasugrel hydrochloride - therapeutic use (9) 9
risk (9) 9
thrombosis (9) 9
ticlopidine - adverse effects (9) 9
ticlopidine - therapeutic use (9) 9
united states (9) 9
aspirin (8) 8
bleeding (8) 8
inhibition (8) 8
piperazines - administration & dosage (8) 8
platelet aggregation - drug effects (8) 8
thiophenes - administration & dosage (8) 8
trial (8) 8
angioplasty, balloon, coronary (7) 7
blood platelets (7) 7
cerebral infarction (7) 7
clinical trials (7) 7
diabetes (7) 7
dose-response relationship, drug (7) 7
events (7) 7
hemorrhage - epidemiology (7) 7
hospitalization (7) 7
infarction (7) 7
longitudinal studies (7) 7
medical colleges (7) 7
medicine, general & internal (7) 7
platelet glycoprotein gpiib-iiia complex - antagonists & inhibitors (7) 7
practice guidelines (7) 7
prasugrel hydrochloride - administration & dosage (7) 7
purinergic p2y receptor antagonists - therapeutic use (7) 7
retrospective studies (7) 7
stroke (7) 7
ticagrelor (7) 7
acute coronary syndrome - diagnosis (6) 6
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of the American College of Cardiology, ISSN 0735-1097, 03/2019, Volume 73, Issue 9, pp. 2911 - 2911
Journal Article
Progress in Cardiovascular Diseases, ISSN 0033-0620, 01/2018, Volume 60, Issue 4-5, pp. 531 - 536
Atrial fibrillation (AF) is a common arrhythmia that increases in prevalence with advancing age and in patients with coronary artery disease,... 
Observation study | Non-vitamin K oral anticoagulant | Atrial fibrillation | Percutaneous coronary intervention | Review | Dual antiplatelet therapy | Triple antithrombotic therapy
Journal Article
Journal Article
Journal Article
Circulation: Cardiovascular Interventions, ISSN 1941-7640, 11/2016, Volume 9, Issue 11, pp. e003602 - e003602
BACKGROUND—Guidelines recommend the use of adenosine diphosphate receptor inhibitor (ADPri) therapy for 1 year postacute myocardial infarction; yet, early... 
major adverse cardiovascular event | stent | Adenosine diphosphate | percutaneous coronary intervention | myocardial infarction | CARDIAC & CARDIOVASCULAR SYSTEMS | MANAGEMENT | TICAGRELOR | THROMBOSIS | AMERICAN-COLLEGE | GUIDELINE | CLOPIDOGREL THERAPY | adenosine diphosphate | DOUBLE-BLIND | ASSOCIATION TASK-FORCE | OUTCOMES | ELUTING STENT IMPLANTATION | Drug Costs | Recurrence | Myocardial Infarction - mortality | Purinergic P2Y Receptor Antagonists - administration & dosage | Percutaneous Coronary Intervention - mortality | United States | Acute Coronary Syndrome - economics | Humans | Middle Aged | Acute Coronary Syndrome - mortality | Male | Practice Patterns, Physicians | Myocardial Infarction - therapy | Purinergic P2Y Receptor Antagonists - adverse effects | Time Factors | Platelet Aggregation Inhibitors - administration & dosage | Ticlopidine - adverse effects | Ticlopidine - economics | Ticlopidine - administration & dosage | Female | Myocardial Infarction - economics | Prasugrel Hydrochloride - administration & dosage | Platelet Aggregation Inhibitors - adverse effects | Myocardial Infarction - diagnosis | Prasugrel Hydrochloride - economics | Drug Administration Schedule | Purinergic P2Y Receptor Antagonists - economics | Risk Factors | Proportional Hazards Models | Treatment Outcome | Prasugrel Hydrochloride - adverse effects | Health Expenditures | Ticlopidine - analogs & derivatives | Medication Adherence | Stroke - etiology | Acute Coronary Syndrome - diagnosis | Acute Coronary Syndrome - therapy | Aged | Longitudinal Studies | Percutaneous Coronary Intervention - adverse effects
Journal Article
Progress in cardiovascular diseases, 01/2018, Volume 60, Issue 4-5, p. 457
Journal Article
Progress in cardiovascular diseases, 01/2018, Volume 60, Issue 4-5, p. 531
Atrial fibrillation (AF) is a common arrhythmia that increases in prevalence with advancing age and in patients with coronary artery disease,... 
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 05/2008, Volume 358, Issue 21, pp. 2205 - 2217
Immediate percutaneous coronary intervention (PCI) is the treatment of choice for acute ST-segment elevation myocardial infarction. In this study, PCI that was... 
IMMEDIATE ANGIOPLASTY | MEDICINE, GENERAL & INTERNAL | PERCUTANEOUS CORONARY INTERVENTION | TO-BALLOON TIME | 30-DAY MORTALITY | INTRAVENOUS THROMBOLYTIC THERAPY | RISK PATIENTS | REPERFUSION THERAPY | SYMPTOM-ONSET | PRIMARY ANGIOPLASTY | FIBRINOLYTIC THERAPY | Myocardial Infarction - mortality | Myocardial Infarction - classification | Humans | Immunoglobulin Fab Fragments - adverse effects | Antibodies, Monoclonal - adverse effects | Antibodies, Monoclonal - therapeutic use | Male | Immunoglobulin Fab Fragments - therapeutic use | Recombinant Proteins - adverse effects | Tissue Plasminogen Activator - adverse effects | Angioplasty, Balloon, Coronary | Fibrinolytic Agents - adverse effects | Myocardial Infarction - therapy | Time Factors | Electrocardiography | Female | Cerebral Infarction - chemically induced | Double-Blind Method | Kaplan-Meier Estimate | Tissue Plasminogen Activator - administration & dosage | Treatment Outcome | Combined Modality Therapy | Recombinant Proteins - administration & dosage | Myocardial Infarction - complications | Aged | Fibrinolytic Agents - administration & dosage | Hemorrhage - chemically induced | Care and treatment | Abciximab | Coronary artery bypass | Comparative analysis | Health aspects | Heart attack | Angioplasty | Heart attacks | Intubation | Index Medicus | Abridged Index Medicus
Journal Article
Journal Article
Journal Article
Journal Article
American Heart Journal, ISSN 0002-8703, 01/2017, Volume 183, pp. 62 - 68
Journal Article
Catheterization and Cardiovascular Interventions, ISSN 1522-1946, 10/2016, Volume 88, Issue 4, pp. 535 - 544
Objectives The 30‐day clinical outcomes with prasugrel or ticagrelor were compared using a US payer database in patients with acute coronary syndrome (ACS)... 
major bleeding | antiplatelet | myocardial infarction | observational study | Coronary Artery Disease
Journal Article
CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, ISSN 1522-1946, 10/2016, Volume 88, Issue 4, pp. 535 - 544
Journal Article